Emerging From the Haze for Gynecologic Cancer Survivors



Status:Completed
Conditions:Cervical Cancer, Cognitive Studies
Therapuetic Areas:Oncology, Psychiatry / Psychology
Healthy:No
Age Range:18 - Any
Updated:1/6/2019
Start Date:January 10, 2017
End Date:November 2017

Use our guide to learn which trials are right for you!

A Pilot Study of Emerging From the Haze Evaluating a Trainee-taught Psycho-educational Program to Improve Cancer-related Cognitive Complaints in Gynecologic Cancer Survivors

At Cedars-Sinai Medical Center, the investigators have developed a novel curriculum for a
6-week psycho-educationally-based, cognitive behavioral program to help patients with
subjective cognitive complaints after cancer treatment, titled Emerging from the Haze™
(Haze). Each series meets once a week for 2-2.5 hours for 6 weeks.

The objective of this study is to quantify the impact of a trainee-taught Emerging from the
Haze course on gynecologic cancer survivors' self-report of cognitive changes based on the
change of FACT-Cog score.


Inclusion Criteria:

- Diagnosis of any stage gynecologic cancer including ovarian, uterine/endometrial,
cervical, vulvar, and vaginal cancer

- Treated with chemotherapy solely or in combination with surgery, radiation, and/or
hormonal therapy

- Female, age ≥ 18 years.

- FACT-Cog score < 59 on the PCI sub scale

- Eligible after 2 months (60 ±5 days) of completing all their active cancer treatment
with the exception of long-term hormonal treatments

- Subjective complaint of cognitive concerns at time of enrollment

- Must be able to understand and communicate proficiently in English

- Ability to understand and the willingness to sign a written informed consent.

- Agree to complete study surveys

Exclusion Criteria:

- Patients who have significant personality disorders or unstable psychiatric disorders
(including active major depression, substance abuse, psychosis or bipolar disorder) as
assessed by the interviewing clinician

- Patients with known brain metastases, history of brain metastases or radiation to the
brain.

- Patients with a history of stroke or other pre-existing neurological condition that
may contribute to cognitive dysfunction.

- Non-English speakers

- Receiving treatment for another malignancy other than breast cancer

- Uncontrolled intercurrent illness including, but not limited to, ongoing or active
infection, chronic anemia, uncontrolled hypothyroidism, symptomatic congestive heart
failure, unstable angina pectoris, uncontrolled cardiac arrhythmia, or psychiatric
illness/social situations that would limit compliance with study requirements.
We found this trial at
1
site
8700 Beverly Blvd # 8211
Los Angeles, California 90048
(1-800-233-2771)
Cedars Sinai Med Ctr Cedars-Sinai is known for providing the highest quality patient care. Our...
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials